Cite
HARVARD Citation
Kadowaki, T. et al. (n.d.). Efficacy, safety and dose–response relationship of teneligliptin, a dipeptidyl peptidase‐4 inhibitor, in Japanese patients with type 2 diabetes mellitus. Diabetes, obesity & metabolism. 15 (9), pp. 810-818. [Online].